Document Detail


Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients.
MedLine Citation:
PMID:  20203627     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Dark chocolate may have blood pressure-lowering properties. We conducted a prospective randomized open-label blinded end-point design trial to study a potential dose dependency of the presumed antihypertensive effect of dark chocolate by directly comparing low vs. higher doses of dark chocolate over the course of 3 months.
METHODS: We enrolled a total of 102 patients with prehypertension/stage 1 hypertension and established cardiovascular end-organ damage or diabetes mellitus. Patients were randomly assigned to receive either 6 or 25 g/day of flavanol-rich dark chocolate for 3 months. The difference in 24-h mean blood pressure between groups was defined as the primary outcome measure.
RESULTS: Significant reductions in mean ambulatory 24-h blood pressure were observed between baseline and follow-up in both groups (6 g/day: -2.3 mm Hg, 95% confidence interval -4.1 to -0.4; 25 g/day: -1.9 mm Hg, 95% confidence interval -3.6 to -0.2). There were no significant differences in blood pressure changes between groups. In the higher-dose group, a slight increase in body weight was noted (0.8 kg, 95% confidence interval 0.06 to 1.6).
CONCLUSIONS: The findings are consistent with the hypothesis that dark chocolate may be associated with a reduction in blood pressure (BP). However, due to the lack of a control group, confounding may be possible and the results should be interpreted with caution.
Authors:
Steffen Desch; Daniela Kobler; Johanna Schmidt; Melanie Sonnabend; Volker Adams; Mahdi Sareban; Ingo Eitel; Matthias Blüher; Gerhard Schuler; Holger Thiele
Related Documents :
19468537 - Alveolar recruitment maneuver in anesthetic practice: how, when and why it may be useful.
210667 - Acute asthma. part ii. the effects of therapy on heart rate and blood pressure.
1734987 - Blood pressure in first 10 years of life: the brompton study.
2486767 - Clinical experience with nadolol in nigerian patients with essential hypertension.
11551377 - The calcium channel blocker controversy in patients with diabetic nephropathy: is there...
1553447 - Effects of hypoxia and hypercapnia on cricothyroid muscle response to airway pressure.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2010-03-04
Journal Detail:
Title:  American journal of hypertension     Volume:  23     ISSN:  1941-7225     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-18     Completed Date:  2010-08-20     Revised Date:  2011-06-30    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  United States    
Other Details:
Languages:  eng     Pagination:  694-700     Citation Subset:  IM    
Affiliation:
Department of Cardiology, University of Leipzig-Heart Center, Leipzig, Germany. stdesch@web.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Pressure / drug effects*
Blood Pressure Monitoring, Ambulatory
Cacao*
Candy
Cardiovascular Diseases / etiology
Diabetes Complications / physiopathology
Female
Humans
Hypertension / complications,  drug therapy*
Male
Risk

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum uric acid levels and renal damage in hyperuricemic hypertensive patients treated with renin-an...
Next Document:  Association of resistin with urinary albumin excretion in nondiabetic patients with essential hypert...